SPROGOE KENNETT

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-03-02	2026-03-02	Ascendis Pharma A/S (ASND)	PrS Proposed sale	70,005 196.36 US$2,351,541	70,005	196.36	US$2,351,541
2025-12-02	2025-12-02	Ascendis Pharma A/S (ASND)	PrS Proposed sale	8,557 175.44 US$623,347	8,557	175.44	US$623,347
2025-05-06	2025-05-06	Ascendis Pharma A/S (ASND)	PrS Proposed sale	85,316 428.05 US$4,754,512	85,316	428.05	US$4,754,512
2025-03-04	2025-03-04	Ascendis Pharma A/S (ASND)	PrS Proposed sale	7,719 152.12 US$1,174,249	7,719	152.12	US$1,174,249
2024-12-10	2024-12-10	Ascendis Pharma A/S (ASND)	PrS Proposed sale	1,222 129.13 US$157,794	1,222	129.13	US$157,794
2024-03-05	2024-03-01	Ascendis Pharma A/S (ASND)	PrS Proposed sale	3,892 150.00 US$583,800	3,892	150.00	US$583,800
2023-09-18	2023-09-18	Ascendis Pharma A/S (ASND)	PrS Proposed sale	45,000 102.66 US$4,619,700	45,000	102.66	US$4,619,700